- Title
- Combination of ciprofloxacin/celecoxib as a novel therapeutic strategy for ALS
- Creators
- Shiran Salomon-Zimri - NeuroSense Therapeutics, Ltd, Herzliya, IsraelAvital Pushett - NeuroSense Therapeutics, Ltd, Herzliya, IsraelNiva Russek-Blum - Dead Sea and Arava Science CenterRuben P.A. Van Eijk - University Medical Center UtrechtNurit Birman - Tel Aviv Sourasky Medical CenterBeatrice Abramovich - Tel Aviv Sourasky Medical CenterErez Eitan - NeuroBioTex (United States)Katya Elgrart - NeuroBioTex (United States)Danielle Beaulieu - Origent Data Sciences, Inc, Vienna, VA, United StatesDavid L. Ennist - Origent Data Sciences, Inc, Vienna, VA, United StatesJames D. Berry - Massachusetts General HospitalSabrina Paganoni - Clinical Research InstituteJeremy M. Shefner - Barrow Neurological InstituteVivian E. Drory - Tel Aviv Sourasky Medical Center
- Publication Details
- Amyotrophic lateral sclerosis and frontotemporal degeneration, Vol.24(3-4), pp.263-271
- Number of pages
- 9
- Identifiers
- 991006262223502656
- Academic Unit
- Neurology
- Language
- English
- Resource Type
- Journal article
Journal article
Combination of ciprofloxacin/celecoxib as a novel therapeutic strategy for ALS
Amyotrophic lateral sclerosis and frontotemporal degeneration, Vol.24(3-4), pp.263-271
04/03/2023
PMID: 36106817
Metrics
1 Record Views